TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35468580

Group type: EXPERIMENTAL
Intervention: 10,000 IU/day of cholecalciferol (vitamin D3) for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2000 IU/day of cholecalciferol (vitamin D3) for 14 days
Number of subjects: 0
Study: 34281611

Group type: EXPERIMENTAL
Intervention: Lower Extremity Constraint-Induced Movement Therapy (LE-CIT) for 2.5 h/day for 15 consecutive days, including intensive supervised training, shaping strategy for motor training, and a transfer package (plus 30 min).
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional physiotherapy for 2.5 h/day for 15 consecutive days.
Number of subjects: 42
Study: 36055581

Group type: EXPERIMENTAL
Intervention: Meals delivered multiple times per week by a Meals on Wheels volunteer or paid driver who may socialize with and provide an informal wellness check
Number of subjects: 236

Group type: COMPARATOR
Intervention: Frozen meals that are mailed to participants' homes every two weeks
Number of subjects: 236
Study: 33624407

Group type: COMPARATOR
Intervention: Principal stratum strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICH E9(R1) estimand framework
Number of subjects: 0
Study: 33151151

Group type: EXPERIMENTAL
Intervention: Platform only (24-week behavior change program with personalized computer-delivered feedback)
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Platform plus coaching (24-week behavior change program plus 12 weeks of personalized feedback by a dietitian)
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Waiting list (nonpersonalized dietary and physical activity recommendations)
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Platform only
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Platform plus coaching
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Longer usage of the platform
Number of subjects: 1298
Study: 36359533

Group type: EXPERIMENTAL
Intervention: Manual therapy in the cervical spine and diaphragm, in combination with breathing reeducation exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cervical spine manual therapy or usual physical therapy care
Number of subjects: 0
Study: 32712663

Group type: EXPERIMENTAL
Intervention: Preemptive therapy (PET) with valganciclovir for 100 days
Number of subjects: 205

Group type: COMPARATOR
Intervention: Prophylaxis with valganciclovir for 100 days
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Preemptive therapy (PET)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Prophylaxis
Number of subjects: 205
Study: 32697707

Group type: COMPARATOR
Intervention: ECT (n = 13)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg over 45 min; n = 12)
Number of subjects: 25
Study: 35120457

Group type: EXPERIMENTAL
Intervention: Aging, Community and Health Research Unit-Community Partnership Program (ACHRU-CPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33962520

Group type: EXPERIMENTAL
Intervention: Waist girth (centimeters)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Ankle plantar flexor strength (kilograms)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Pain at multiple sites (pain at 1 other site)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Pain at multiple sites (pain at 4 or more other sites)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Pain catastrophizing status (some)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Pain catastrophizing status (catastrophizer)
Number of subjects: 220
Study: 34859602

Group type: EXPERIMENTAL
Intervention: Gamified mobile health intervention (mobile game designed for children)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Routine care with mobile game
Number of subjects: 124
Study: 35183768

Group type: EXPERIMENTAL
Intervention: AFI-guided probe-based confocal laser endomicroscopy (pCLE)
Number of subjects: 154

Group type: COMPARATOR
Intervention: HRWLE with Seattle protocol biopsies
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 3-biomarker panel (pCLE optical dysplasia, aberrant p53, aneuploidy)
Number of subjects: 154
Study: 33406353

Group type: EXPERIMENTAL
Intervention: Convalescent plasma with high IgG titers
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Convalescent plasma with high IgG titers (modified intention-to-treat analysis)
Number of subjects: 160
Study: 35511610

Group type: EXPERIMENTAL
Intervention: Fish intake
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Meat intake
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sugar-sweetened beverages (SSBs) intake
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Plasma NIRLeucine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Plasma NIRGlutamic acid/glutamine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Plasma NIRProline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RBC NIRProline
Number of subjects: 32
Study: 36474770

Group type: EXPERIMENTAL
Intervention: 75 mg S201086/GLPG1972
Number of subjects: 852

Group type: EXPERIMENTAL
Intervention: 150 mg S201086/GLPG1972
Number of subjects: 852

Group type: EXPERIMENTAL
Intervention: 300 mg S201086/GLPG1972
Number of subjects: 852

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 852
Study: 34414430

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 666

Group type: COMPARATOR
Intervention: Beta blockers
Number of subjects: 666

Group type: COMPARATOR
Intervention: No rate control drugs
Number of subjects: 666
Study: 33950868

Group type: EXPERIMENTAL
Intervention: Anterior approach injection (54 patients)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Posterior approach injection (41 patients)
Number of subjects: 95
Study: 32445609

Group type: EXPERIMENTAL
Intervention: PEEP 3 cmH2 O without recruitment maneuver
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEEP 3 cmH2 O with recruitment maneuver
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEEP 7 cmH2 O without recruitment maneuver
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEEP 7 cmH2 O with recruitment maneuver
Number of subjects: 57
Study: 34652088

Group type: EXPERIMENTAL
Intervention: Continuous Aerobic (CA) exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Interval Aerobic (IA) exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance (RE) exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study: 34510814

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (degarelix)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GnRH agonist (leuprorelin acetate or goserelin acetate)
Number of subjects: 0
Study: 33162294

Group type: EXPERIMENTAL
Intervention: Slope-configured implants (test group)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Regular-configured implants (control group)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Adjacent teeth (GCF biomarkers)
Number of subjects: 19
Study: 32925729

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Obturator nerve block (ONB)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: FNB
Number of subjects: 200

Group type: COMPARATOR
Intervention: ONB
Number of subjects: 200
Study: 36483124

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LM) intervention for 4 months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Mindful self-compassion (MSC) training for 2 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (cooking/dietary education)
Number of subjects: 28
Study: 33952329

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning using total occlusion pressure
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning with 40% more than total occlusion pressure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (10 mmHg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 35781462

Group type: EXPERIMENTAL
Intervention: 1‰ PL‐5 spray
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 2‰ PL‐5 spray
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: 4‰ PL‐5 spray
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (silver sulfadiazine)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: PL‐5 spray
Number of subjects: 220
Study: 33893842

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Light-emitting diode therapy (LEDT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both LLLT and LEDT
Number of subjects: 80
Study: 32407451

Group type: EXPERIMENTAL
Intervention: Vismodegib treatment
Number of subjects: 244
Study: 35801741

Group type: EXPERIMENTAL
Intervention: 4‐hour 1 + 2L bowel preparation regimen
Number of subjects: 600

Group type: COMPARATOR
Intervention: 6‐hour 1 + 2L bowel preparation regimen
Number of subjects: 600

Group type: COMPARATOR
Intervention: 4‐hour 0 + 2L bowel preparation regimen
Number of subjects: 600
Study: 34034372

Group type: EXPERIMENTAL
Intervention: ERAS group (group E)
Number of subjects: 90
Study: 32297095

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game integrated with PATHS curriculum
Number of subjects: 1526

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game only
Number of subjects: 1526

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1526
Study: 34724085

Group type: EXPERIMENTAL
Intervention: Standard-dose radiotherapy (3.0 Gy total, 0.5 Gy twice weekly)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Very-low-dose radiotherapy (0.3 Gy total, 0.05 Gy twice weekly)
Number of subjects: 236
Study: 33374006

Group type: EXPERIMENTAL
Intervention: Rifapentine (specific dosage not mentioned)
Number of subjects: 173
Study: 33011172

Group type: EXPERIMENTAL
Intervention: LHe 5.6 M
Number of subjects: 0

Group type: COMPARATOR
Intervention: LN 5.6 M
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LN 6.6 M
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LHe 6.6 M
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LHe (−269 °C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LN (−196 °C)
Number of subjects: 0
Study: 35140514

Group type: EXPERIMENTAL
Intervention: IV lidocaine during anaesthesia
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (normal saline) during anaesthesia
Number of subjects: 96
Study: 34086447

Group type: EXPERIMENTAL
Intervention: Sanitation intervention (household latrines)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no sanitation intervention)
Number of subjects: 0
Study: 32056507

Group type: EXPERIMENTAL
Intervention: CT-based implant motion analysis (CTMA) using surface anatomy of the pelvis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CT-based implant motion analysis (CTMA) using beads
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CT-based implant motion analysis (CTMA)
Number of subjects: 24
Study: 34432089

Group type: EXPERIMENTAL
Intervention: Mesh hysteropexy
Number of subjects: 175

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 175
Study: 32297782

Group type: EXPERIMENTAL
Intervention: 6 mg/mL nicotine e‐liquid
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 12 mg/mL nicotine e‐liquid
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Green apple e‐liquid
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Menthol e‐liquid
Number of subjects: 49

Group type: COMPARATOR
Intervention: Unflavored e‐liquid
Number of subjects: 49
Study: 32122230

Group type: EXPERIMENTAL
Intervention: Vortioxetine (10 mg b.i.d.)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 36307493

Group type: EXPERIMENTAL
Intervention: Oligo-fucoidan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 20
Study: 33115675

Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 32390339

Group type: EXPERIMENTAL
Intervention: Self-management program (SMP) intervention for 4 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 58
Study: 34301736

Group type: EXPERIMENTAL
Intervention: Personalized postprandial-targeting (PPT) diet
Number of subjects: 225

Group type: COMPARATOR
Intervention: Mediterranean (MED) diet
Number of subjects: 225
Study: 35754324

Group type: EXPERIMENTAL
Intervention: Virtual clinic
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine outpatient clinical care (Control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 33739883

Group type: EXPERIMENTAL
Intervention: HDR‐2 (900 mg per day for 8 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (900 mg per day for 8 weeks)
Number of subjects: 88
Study: 34282977

Group type: EXPERIMENTAL
Intervention: RPT (Relationship Profile Test)
Number of subjects: 661
Study: 33774921

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1034
Study: 32169310

Group type: EXPERIMENTAL
Intervention: Higher IGF-1 concentrations
Number of subjects: 206263

Group type: EXPERIMENTAL
Intervention: Genetically-predicted IGF-1 concentration
Number of subjects: 206263

Group type: EXPERIMENTAL
Intervention: Genetically-predicted IGFBP-3 concentrations
Number of subjects: 206263
Study: 35872448

Group type: EXPERIMENTAL
Intervention: Real tDCS stimulation (anodal electrical stimulation at 2 mA for 20 min once daily for 7 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Real tDCS stimulation
Number of subjects: 24
Study: 32730170

Group type: EXPERIMENTAL
Intervention: Graphic Organizers (GOs)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Flash Cards (FCs)
Number of subjects: 59
Study: 32227142

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (audit feedback with targeted suggestions, a 7-week quality improvement collaborative, and best-practice sharing)
Number of subjects: 864080

Group type: COMPARATOR
Intervention: Audit feedback alone
Number of subjects: 864080
Study: 34137239

Group type: EXPERIMENTAL
Intervention: Left distal transradial angiography (ldTRA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Transfemoral angiography (TFA)
Number of subjects: 57
Study: 33395671

Group type: EXPERIMENTAL
Intervention: Sustained attention to response task (SART) in ALS patients
Number of subjects: 57

Group type: COMPARATOR
Intervention: SART in healthy controls
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Beta-band ERD in ALS patients
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Higher ECAS ALS-specific scores in ALS patients
Number of subjects: 57
Study: 32723374

Group type: EXPERIMENTAL
Intervention: 20% mannitol
Number of subjects: 34

Group type: COMPARATOR
Intervention: 0.9% NaCl placebo
Number of subjects: 34
Study: 35522399

Group type: COMPARATOR
Intervention: Standard medical care only (SMC)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Expectations optimization (EXPECT)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Emotional support
Number of subjects: 115
Study: 33550243

Group type: EXPERIMENTAL
Intervention: Enteral DHA supplementation (60 mg/kg/day)
Number of subjects: 1273

Group type: COMPARATOR
Intervention: Control emulsion (without DHA)
Number of subjects: 1273

Group type: EXPERIMENTAL
Intervention: Cognitive assessment at 5 years of age
Number of subjects: 1273
Study: 34613973

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) combined with physiotherapeutic exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham PBM combined with physiotherapeutic exercises
Number of subjects: 30
Study: 32859615

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 139

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 139

Group type: COMPARATOR
Intervention: Exercise and Metformin
Number of subjects: 139
Study: 35464450

Group type: EXPERIMENTAL
Intervention: OVX836 (180µg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: OVX836 (90µg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Influvac Tetra (control)
Number of subjects: 300
Study: 33033956

Group type: EXPERIMENTAL
Intervention: Aerosol box
Number of subjects: 38

Group type: COMPARATOR
Intervention: No aerosol box
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Aerosol box (normal airway)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No aerosol box (normal airway)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Aerosol box (difficult airway)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No aerosol box (difficult airway)
Number of subjects: 38
Study: 33814393

Group type: EXPERIMENTAL
Intervention: Removable dental splint-teethguard
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Removable splint-teethguards and transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 60
Study: 32451320

Group type: EXPERIMENTAL
Intervention: WATCHMAN
Number of subjects: 641

Group type: COMPARATOR
Intervention: ACP/Amulet
Number of subjects: 641
Study: 36173147

Group type: EXPERIMENTAL
Intervention: SKILLZ Health for Girls programme (sports-based sexual education intervention)
Number of subjects: 38
Study: 33493373

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard treatment with an opioid
Number of subjects: 3
Study: 32282379

Group type: EXPERIMENTAL
Intervention: Self-reported harmful medical error
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported near miss medical error
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Burnout symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poor psychiatric well-being
Number of subjects: 0

Group type: COMPARATOR
Intervention: Program-level resident wellness
Number of subjects: 0
Study: 36172693

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM) with alert functionality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittently scanned continuous glucose monitoring (isCGM) without alerts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM)
Number of subjects: 0
Study: 34769707

Group type: EXPERIMENTAL
Intervention: WeChat-based smoking cessation intervention
Number of subjects: 403
Study: 32352250

Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate gel 0.5%
Number of subjects: 105

Group type: COMPARATOR
Intervention: Prednisolone acetate suspension 1%
Number of subjects: 105
Study: 35727234

Group type: EXPERIMENTAL
Intervention: Split-mouth trials
Number of subjects: 244
Study: 33467876

Group type: EXPERIMENTAL
Intervention: Goal-setting instructions (n=36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard instructions (n=36)
Number of subjects: 72
Study: 35511296

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 34404290

Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pimavanserin augmentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pimavanserin augmentation of antipsychotics
Number of subjects: 0
Study: 32920219

Group type: EXPERIMENTAL
Intervention: Patients with perinephric fat stranding (PFS) - Group A (38 patients)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Patients without perinephric fat stranding (PFS) - Group B (44 patients)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (80 subjects with no kidney diseases)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 82
Study: 34679162

Group type: EXPERIMENTAL
Intervention: MI Varnish applied every 4-6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: ProSeal sealant with reapplications every 3 months
Number of subjects: 40
Study: 32869527

Group type: EXPERIMENTAL
Intervention: Oral HIV self-tests (HIVST) distributed in intervention clusters
Number of subjects: 2671

Group type: COMPARATOR
Intervention: Control group with no self-tests distributed
Number of subjects: 2671
Study: 33118847

Group type: EXPERIMENTAL
Intervention: Iguratimod
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 32871534

Group type: EXPERIMENTAL
Intervention: six IV ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: single IV ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: five IV midazolam followed by a single IV ketamine
Number of subjects: 0
Study: 36408722

Group type: EXPERIMENTAL
Intervention: Tailored digitally enabled exercise intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 300
Study: 33574125

Group type: EXPERIMENTAL
Intervention: Imeglimin (1,000 mg twice daily)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 32044975

Group type: EXPERIMENTAL
Intervention: Angiographic visual inspection (AVI alone)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Angiographic visual inspection plus fractional flow reserve (AVI plus FFR)
Number of subjects: 11
Study: 35066653

Group type: EXPERIMENTAL
Intervention: R-LPS (laboratory prognostic score) based on 8 indices
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: 8 independent prognostic factors for 14-day survival
Number of subjects: 649
Study: 32789898

Group type: EXPERIMENTAL
Intervention: SITall-out (n = 11)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: SIT120 (n = 12)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: HIIT90 (n = 12)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: MICT (n = 11)
Number of subjects: 59

Group type: COMPARATOR
Intervention: CON (n = 13)
Number of subjects: 59
Study: 35796215

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Face-to-face cognitive behavioral therapy (CBT)
Number of subjects: 0
Study: 32752234

Group type: EXPERIMENTAL
Intervention: Individual physiotherapy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Group physiotherapy
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Secondary analysis (data carried forward from week 12)
Number of subjects: 136
Study: 35656851

Group type: EXPERIMENTAL
Intervention: Refill-based opioid prescription method (experimental arm)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control arm (single prescription for all postoperative narcotics)
Number of subjects: 48